Joel Greenblatt's TBPH Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 45,212 shares of Theravance Biopharma, Inc. (TBPH) worth $733,791, representing 0.00% of the portfolio. First purchased in 2015-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in TBPH for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 22,680 shares. Largest reduction occurred in Q1 2016, reducing 69,582 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Theravance Biopharma (TBPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Theravance Biopharma (TBPH) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +22,532 | Add 99.35% | 45,212 | $16.23 |
| Q4 2025 | +22,680 | New Buy | 22,680 | $18.71 |
| Q1 2017 | -9,571 | Sold Out | 0 | $0.00 |
| Q4 2016 | +9,571 | New Buy | 9,571 | $31.87 |
| Q1 2016 | -69,582 | Sold Out | 0 | $0.00 |
| Q4 2015 | +69,582 | New Buy | 69,582 | $10.53 |
Joel Greenblatt's Theravance Biopharma Investment FAQs
Joel Greenblatt first purchased Theravance Biopharma, Inc. (TBPH) in Q4 2015, acquiring 69,582 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Theravance Biopharma, Inc. (TBPH) for 6 quarters since Q4 2015.
Joel Greenblatt's largest addition to Theravance Biopharma, Inc. (TBPH) was in Q4 2015, adding 69,582 shares worth $733,000.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 45,212 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $733,791.
As of the Q1 2026 filing, Theravance Biopharma, Inc. (TBPH) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Theravance Biopharma, Inc. (TBPH) was 69,582 shares, as reported at the end of Q4 2015.